Artificial intelligence stocks growing shareholder value

With the rapid rise of artificial intelligence and its promises of increased efficiency, public stocks are rushing to integrate it and capitalize on the well-deserved hype.

According to Fortune Business Insights, the global AI market will grow from US$515.31 billion in 2023 to over US$2 trillion by 2030. This staggering trajectory is because of AI’s ability to learn and solve problems at a speed and scale beyond human possibility. Examples include processing large quantities of data to:

• Identify ideal customers and increase conversion rates
• Track disease patterns to improve diagnosis and stifle outbreaks
• Determine the safest routes for self-driving cars
• Flag suspicious banking activity
• Detect threats and prevent tragedies in high-traffic spaces
• Draft text, video or images on demand in mere instants, significantly expediting the creative process

Such a global boost to industrial productivity reached the mainstream because of ChatGPT, a chatbot trained to give detailed answers to virtually any query you can think of. The program surpassed 100 million users only two months after its official launch, priming the general public to pay close attention to investable opportunities in the space.

Much like with cryptocurrency and the dot-com bubbles before it, hundreds of stocks across the market cap spectrum have been quick to act on AI’s expanding spotlight, proudly extolling the benefits of their new AI initiatives, but also creating a problem for investors unsure about separating bandwagoners from value-added participants.

To point our readers in the right direction, we have compiled recent stories from three artificial intelligence stocks that encapsulate their focus on shareholder value creation.

Empower Clinics announces spin-out proposal

Empower Clinics (CSE:EPW), an integrated healthcare company, intends to spin out a wholly owned subsidiary and vend in a healthcare artificial intelligence technology company.

Shares of the proposed AI company, to be listed on the CSE, would be distributed to Empower shareholders on a pro-rata basis.

Empower, a new entrant in clinical research, is capitalizing on its belief that healthcare will benefit from AI advancements in faster and more thorough patient recruitment. It is conducting due diligence on numerous AI platforms and companies in anticipation of the listing.

CEO Steven McAuley spoke with our Sabrina Phillips about the news.

The spin-out follows a lengthy strategic review process to accelerate profitability, which has resulted in a contract for pharmaceutical research and clinical trial services and a C$5 million equity capital facility. 

Empower Clinics stock (CSE:EPW) has fallen by 88.75 per cent over the past year.

Nextech3D.ai delivers 50,000th 3D model

Nextech3D.ai (CSE:NTAR), an augmented reality and generative AI company, achieved a new production milestone having delivered more than 50,000 3D models.

Increasing 3D model demand resulted in Q2 revenue of C$1.4 million, up by more than 155 per cent YoY, with an estimate of C$1.7 million to C$1.9 million in Q3 positioning the company to surpass the 200 per cent YoY mark.

CEO Evan Gappelberg expects Q3 “to be the long-awaited turning point for our company,” according to a recent statement, as high-profile customers such as Amazon, P&G, Kohl’s and other major retailers increasingly turn to Nextech’s photo-realistic models to enhance the shopping experience and maximize ROI.

Gappelberg recently spoke with our Brieanna McCutcheon about his confidence in the company becoming a leader in 3D modelling.

The 50,000-model milestone follows a $2.2 million 3D model contract from Amazon and a $2.5 million financing with participation from Gappelberg.

Nextech3D.ai stock (CSE:NTAR) is down by 62.38 per cent over the past year despite its exponential revenue growth and accretive industry tailwinds.

Liberty Defense to supply multiple HEXWAVE units to Los Alamos National Laboratory

Liberty Defense Holdings (TSXV:SCAN), a developer of AI-based threat detection solutions, is announcing a HEXWAVE order from the Los Alamos National Laboratory for initial testing.

HEXWAVE uses millimeter wave, advanced 3D imaging and AI to identify concealed metallic and non-metallic items – including liquid, plastic and powder explosives – without the need for a pat-down.

The New-Mexico-based Los Alamos Lab is a federally funded research and development organization for the U.S. Department of Energy’s National Nuclear Security Administration. The organization is spread across 900 facilities employing more than 17,000 people.

CEO Bill Frain joined Brieanna McCutcheon to shed light on the new business.

The Los Alamos order follows expansion activities in New Hampshire and Indiana, as well as initial European expansion through Netherlands-based partner GRASP Innovations.

Liberty Defense Holdings (TSXV:SCAN) is down by 28.33 per cent over the past year.

Join the discussion: Find out what everybody’s saying about artificial intelligence stocks on the Empower Clinics, Nextech3D.ai and Liberty Defense Bullboards, as well as Stockhouse’s stock forums and message boards.

This is sponsored content issued on behalf of Empower Clinics, Nextech3D.ai and Liberty Defense, please see full disclaimer here.